X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (11) 11
adult (9) 9
aged (9) 9
female (9) 9
humans (9) 9
index medicus (9) 9
male (9) 9
middle aged (9) 9
patients (9) 9
transplantation (9) 9
analysis (7) 7
lymphomas (7) 7
chemotherapy (6) 6
oncology (6) 6
stem cells (6) 6
b-cell lymphoma (5) 5
lymphoma (5) 5
survival (5) 5
young adult (5) 5
adolescent (4) 4
aged, 80 and over (4) 4
cancer (4) 4
cancer therapies (4) 4
drug therapy (4) 4
hematology, oncology and palliative medicine (4) 4
leukemia (4) 4
prognosis (4) 4
survival analysis (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
biotechnology & applied microbiology (3) 3
care and treatment (3) 3
cox-2 (3) 3
disease (3) 3
drug dosages (3) 3
lymphocytes b (3) 3
medicine (3) 3
multivariate analysis (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
non-hodgkin's lymphomas (3) 3
non-hodgkins-lymphoma (3) 3
oncotargets and therapy (3) 3
recurrence (3) 3
relapse (3) 3
research article (3) 3
retrospective studies (3) 3
risk factors (3) 3
science (3) 3
treatment outcome (3) 3
bone marrow (2) 2
case report (2) 2
celecoxib (2) 2
child (2) 2
clarithromycin (2) 2
clinical medicine (2) 2
combined modality therapy (2) 2
community-acquired infections (2) 2
cox-2 inhibitors (2) 2
cytarabine (2) 2
development and progression (2) 2
diagnosis (2) 2
disease-free survival (2) 2
dlbcl (2) 2
doxorubicin (2) 2
erythromycin (2) 2
expression (2) 2
gemcitabine (2) 2
genetic aspects (2) 2
graft-versus-host reaction (2) 2
hematopoietic stem cell transplantation - adverse effects (2) 2
hematopoietic stem cells (2) 2
hemic and lymphatic diseases (2) 2
high-dose chemotherapy (2) 2
hodgkin lymphoma (2) 2
immunotherapy (2) 2
incidence (2) 2
legionella pneumophila (2) 2
lymphoma, large b-cell, diffuse - mortality (2) 2
lymphoma, large b-cell, diffuse - pathology (2) 2
medical prognosis (2) 2
multicenter (2) 2
multidisciplinary sciences (2) 2
myelodysplastic syndromes (2) 2
pathology (2) 2
patient outcomes (2) 2
pharmacy (2) 2
phase-ii (2) 2
pneumonia (2) 2
prophylaxis (2) 2
radiation therapy (2) 2
retreatment (2) 2
rhabdomyolysis (2) 2
rifampin (2) 2
risk (2) 2
risk assessment (2) 2
risk groups (2) 2
rituximab (2) 2
salvage therapy (2) 2
stem-cell transplantation (2) 2
t cells (2) 2
thalidomide (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Relaciones Internacionales, 10/2017, Issue 36, pp. 51 - 71
El grado de inclusión y protección que se podrá ofrecer a la población refugiada en los países de asilo de la Unión Europea depende de factores adicionales a... 
Integration | Asylum | Centrality | Families & family life | Access to information | Reunions | Refugees
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, pp. e0179595 - e0179595
Central nervous system (CNS) lymphomatosis is a fatal complication of aggressive non-Hodgkin lymphoma (NHL). In lymphoblastic or Burkitt lymphoma, without... 
PRIMARY CNS LYMPHOMA | TRIAL | RELAPSE | B-CELL LYMPHOMA | HIGH-RISK PATIENTS | THERAPY | MULTIDISCIPLINARY SCIENCES | METHOTREXATE | NON-HODGKIN-LYMPHOMA | LEUKEMIA | RITUXIMAB ERA | Injections, Spinal | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Cytarabine - adverse effects | Young Adult | Antimetabolites, Antineoplastic - therapeutic use | Burkitt Lymphoma - prevention & control | Central Nervous System Neoplasms - prevention & control | Adolescent | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Liposomes | Central Nervous System Neoplasms - drug therapy | Child | Burkitt Lymphoma - drug therapy | Prevention | Complications and side effects | Central nervous system diseases | Genetic aspects | Non-Hodgkin's lymphomas | Research | Risk factors | Therapy | Headache | Intravenous administration | Toxicity | Leukemia | Prophylaxis | Central nervous system | Clinical trials | Nervous system | Cerebrospinal fluid | Cancer therapies | Incidence | Cytarabine | Vomiting | Colony-stimulating factor | Methotrexate | Dexamethasone | Effectiveness | Hematology | Nausea | Patients | Survival | Lymphoma | Fever | Burkitt's lymphoma | Neurological diseases | Chemotherapy | Medical prognosis | Pharmacy | Blindness | Death | Lymphomas | Testes | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5398 - 5398
Abstract Red cell distribution width (RDW) is an indicator of the variability in the size of circulating erythrocytes (anisocytosis); different conditions can... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2018, Volume 182, Issue 4, pp. 534 - 541
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, p. e0123978
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, p. e0140454
Journal Article
European Journal of Haematology, ISSN 0902-4441, 09/2018, Volume 101, Issue 3, pp. 332 - 339
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5373 - 5373
Abstract Red cell distribution width (RDW) is an indicator of the variability in the size of circulating erythrocytes (anisocytosis); different conditions can... 
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 1, pp. 84 - 90
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4690 - 4690
Abstract Introduction: Allogeneic transplantation is the only curative option for patients with high risk leukemias or MDS. Only one third of them have an HLA... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2016, Volume 174, Issue 6, pp. 899 - 910
Journal Article